Plain-English translation of NCT04665388 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying tumor tissue from patients with three types of cancer—those linked to EBV virus, HPV virus, and liver cancer—to understand how the immune system recognizes and fights cancer cells. The goal is to identify which specific cancer targets and immune cell receptors could be used to design personalized treatments that harness your own immune system to attack cancer.
Currently, doctors don't have a complete map of which cancer targets and immune responses work across different cancer types and different populations. This study aims to create that map so future treatments can be tailored to each patient's specific cancer and genetic makeup.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would donate a tissue sample from your tumor—either existing tissue that's already been collected or newly collected tissue if medically appropriate. This is a one-time contribution; there are no ongoing visits or long-term commitments. Researchers will analyze your tissue to identify immune targets specific to your cancer type.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Canada
Enrollment target
~105 participants
Started
November 2020
Primary completion
February 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kathy Han, MD
Princess Margaret Cancer Centre
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.